|
MTCH2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.840300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.499450E-03 |
| Normal-vs-Stage2 |
5.141000E-01 |
| Normal-vs-Stage3 |
7.77270000000829E-05 |
| Normal-vs-Stage4 |
6.06539999999933E-05 |
| Stage1-vs-Stage2 |
6.019800E-03 |
| Stage1-vs-Stage3 |
1.847820E-01 |
| Stage1-vs-Stage4 |
1.201440E-01 |
| Stage2-vs-Stage3 |
1.195540E-03 |
| Stage2-vs-Stage4 |
7.046300E-04 |
| Stage3-vs-Stage4 |
5.999600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.00400000000189E-05 |
| Normal-vs-AfricanAmerican |
4.891600E-02 |
| Normal-vs-Asian |
9.695900E-03 |
| Caucasian-vs-AfricanAmerican |
5.241400E-01 |
| Caucasian-vs-Asian |
6.534000E-01 |
| AfricanAmerican-vs-Asian |
8.236200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.046000E-04 |
| Normal-vs-Female |
6.417300E-03 |
| Male-vs-Female |
1.239570E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.998930E-03 |
| Normal-vs-Age(41-60Yrs) |
6.567300E-04 |
| Normal-vs-Age(61-80Yrs) |
8.925600E-02 |
| Normal-vs-Age(81-100Yrs) |
6.083900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.271600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.292400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.532000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.163160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.331000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.807410E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.629800E-01 |
| Classical-VS-Follicular |
5.186100E-04 |
| Classical-VS-Other |
4.895200E-01 |
| Classical-VS-Normal |
3.619900000007E-05 |
| Tall-VS-Follicular |
3.678900E-03 |
| Tall-VS-Other |
3.919400E-01 |
| Tall-VS-Normal |
2.640000E-03 |
| Follicular-VS-Other |
1.378800E-01 |
| Follicular-VS-Normal |
8.466800E-01 |
| Other-VS-Normal |
2.091900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.000300E-02 |
| Normal-vs-N1 |
6.8056000002148E-07 |
| N0-vs-N1 |
2.903800E-03 |
|
|
